TP53BP1 and head and neck cancer: The nonirradiated control (before RT) showed a low number of foci in patients with head and neck cancer (0.37 ± 0.02 53BP1 foci/cell) and in those with rectal cancer (0.33 ± 0.08 53BP1 foci/cell).